Alex Michael Ward is a virologist and cell biologist seeking a research position in biotech. He has 14 years of experience studying virus-host interactions and identifying therapeutic targets using genetic, proteomic, and cell-based approaches. He is a highly collaborative scientist who has independently managed a research team and obtained external funding. His work has resulted in numerous publications, presentations, and the development of novel assays.
This document provides a summary of Swarnava Roy's background and qualifications. It outlines her extensive experience in molecular immunology, clinical research, and various laboratory techniques gained from her positions at research institutes including the National Institutes of Health and Cincinnati Children's Hospital Medical Center. It also lists her educational background, publications, awards, and teaching experience, demonstrating her expertise in areas of molecular biology, biochemistry, and immunology.
The document provides a summary of the qualifications and experience of David C. Crosby, Ph.D. It includes his contact information and outlines his experience in medical science liaison roles in infectious disease, as well as his background in virology research. It also lists his education, publications, presentations, and professional affiliations.
David C. Crosby is a medical science liaison with over 15 years of experience in infectious disease research and medical communications. He has worked at several biotech companies, including his current role at Melinta Therapeutics where he engages with key opinion leaders to discuss Melinta's antibiotic pipeline. Crosby also has a background in virology research, having conducted HIV/AIDS studies at the University of California, San Francisco and the University of California, Irvine where he received his Ph.D. He is experienced in scientific engagement, competitive intelligence gathering, and distilling medical information for commercial and clinical functions.
This document provides a summary of the qualifications and experience of Francesca Madiai, PhD. She has over 10 years of experience as a clinical research coordinator, with expertise in areas such as project planning, data collection, protocol development, and GCP compliance. Her background includes a PhD in Molecular, Cellular and Developmental Biology from Ohio State University and over 10 publications in scientific journals. She has coordinated over 50 clinical trials in rheumatology and has experience with regulatory submissions, study execution, and patient recruitment.
This document summarizes a seminar presentation on using bioinformatics in pandemics. The presentation was given by Puneeth V G at Sahyadri Science College and discussed how bioinformatics can help shorten the time needed to identify drug and vaccine targets during a pandemic. It explained that bioinformatics tools like genome sequencing and comparative genomics can be used to find overlapping genes between host and pathogen genomes, identify unique pathogen sequences, and ultimately find protein targets that could be used for vaccines or drugs. The presentation highlighted that bioinformatics allows for more rapid identification of targets with fewer resources during a pandemic compared to traditional methods.
Robert Pesich_PAVA_Stanford Resume v. 8_22_16Robert Pesich
Robert Pesich has extensive experience managing laboratory operations and research projects. He has overseen the daily activities of 25 researchers at Stanford University and the Palo Alto VA, including managing budgets, equipment, and regulatory compliance. Pesich has specialized skills in tissue sample processing, gene expression analysis, and bioinformatics. He has authored several publications characterizing gene expression profiles in normal and diseased tissues. Currently, Pesich also serves as President of a poetry non-profit organization.
This document provides a summary of Alexander Polinkovsky's professional experience and education. It lists his positions from 2014 to present as a clinical and biomedical research consultant. It also outlines his previous roles as a research lab manager and researcher from 2011 to 2014 at the Louis Stokes V.A. Medical Center and from 2009 to 2011 at Case Western Reserve University. It notes that he has a Ph.D. in Biology and Virology from 1981 and has experience in areas like microbiome studies, DNA/RNA extraction, metabolomics, and proteomics.
Joseph Granger one page resume times new romanJoseph Granger
Joseph B. Granger has extensive education and experience in biochemistry. He received his M.S. in Biochemistry from Dartmouth College where he developed nanoparticles to inhibit ACAT1 in the CNS. As a Ph.D. candidate at Dartmouth, he produced peptide-tagged liposomes and micelles to deliver therapeutics to treat Alzheimer's disease models. He has proficiency in various laboratory techniques and software programs. Granger has experience teaching biochemistry and conducting undergraduate research investigating the structure-function relationship of a bacterial regulator protein.
This document provides a summary of Swarnava Roy's background and qualifications. It outlines her extensive experience in molecular immunology, clinical research, and various laboratory techniques gained from her positions at research institutes including the National Institutes of Health and Cincinnati Children's Hospital Medical Center. It also lists her educational background, publications, awards, and teaching experience, demonstrating her expertise in areas of molecular biology, biochemistry, and immunology.
The document provides a summary of the qualifications and experience of David C. Crosby, Ph.D. It includes his contact information and outlines his experience in medical science liaison roles in infectious disease, as well as his background in virology research. It also lists his education, publications, presentations, and professional affiliations.
David C. Crosby is a medical science liaison with over 15 years of experience in infectious disease research and medical communications. He has worked at several biotech companies, including his current role at Melinta Therapeutics where he engages with key opinion leaders to discuss Melinta's antibiotic pipeline. Crosby also has a background in virology research, having conducted HIV/AIDS studies at the University of California, San Francisco and the University of California, Irvine where he received his Ph.D. He is experienced in scientific engagement, competitive intelligence gathering, and distilling medical information for commercial and clinical functions.
This document provides a summary of the qualifications and experience of Francesca Madiai, PhD. She has over 10 years of experience as a clinical research coordinator, with expertise in areas such as project planning, data collection, protocol development, and GCP compliance. Her background includes a PhD in Molecular, Cellular and Developmental Biology from Ohio State University and over 10 publications in scientific journals. She has coordinated over 50 clinical trials in rheumatology and has experience with regulatory submissions, study execution, and patient recruitment.
This document summarizes a seminar presentation on using bioinformatics in pandemics. The presentation was given by Puneeth V G at Sahyadri Science College and discussed how bioinformatics can help shorten the time needed to identify drug and vaccine targets during a pandemic. It explained that bioinformatics tools like genome sequencing and comparative genomics can be used to find overlapping genes between host and pathogen genomes, identify unique pathogen sequences, and ultimately find protein targets that could be used for vaccines or drugs. The presentation highlighted that bioinformatics allows for more rapid identification of targets with fewer resources during a pandemic compared to traditional methods.
Robert Pesich_PAVA_Stanford Resume v. 8_22_16Robert Pesich
Robert Pesich has extensive experience managing laboratory operations and research projects. He has overseen the daily activities of 25 researchers at Stanford University and the Palo Alto VA, including managing budgets, equipment, and regulatory compliance. Pesich has specialized skills in tissue sample processing, gene expression analysis, and bioinformatics. He has authored several publications characterizing gene expression profiles in normal and diseased tissues. Currently, Pesich also serves as President of a poetry non-profit organization.
This document provides a summary of Alexander Polinkovsky's professional experience and education. It lists his positions from 2014 to present as a clinical and biomedical research consultant. It also outlines his previous roles as a research lab manager and researcher from 2011 to 2014 at the Louis Stokes V.A. Medical Center and from 2009 to 2011 at Case Western Reserve University. It notes that he has a Ph.D. in Biology and Virology from 1981 and has experience in areas like microbiome studies, DNA/RNA extraction, metabolomics, and proteomics.
Joseph Granger one page resume times new romanJoseph Granger
Joseph B. Granger has extensive education and experience in biochemistry. He received his M.S. in Biochemistry from Dartmouth College where he developed nanoparticles to inhibit ACAT1 in the CNS. As a Ph.D. candidate at Dartmouth, he produced peptide-tagged liposomes and micelles to deliver therapeutics to treat Alzheimer's disease models. He has proficiency in various laboratory techniques and software programs. Granger has experience teaching biochemistry and conducting undergraduate research investigating the structure-function relationship of a bacterial regulator protein.
The document provides a summary of Swadesh Das's professional experience and qualifications. It summarizes that he has over 10 years of experience in research, particularly in microbiology and molecular oncology. He currently works as a research faculty at Virginia Commonwealth University, where he manages research projects and pursues patent applications. He has a PhD in Life Science and expertise in areas like molecular biology, cancer research, and biomarker identification.
This document provides a summary of Robert S. Coyne's career experience and qualifications. It outlines his educational background, current position as an Associate Professor at the J. Craig Venter Institute, past appointments, research interests in genomics and ciliate biology, grants awarded, and publications. Coyne has over 30 years of experience in research focusing on genome structure, rearrangement, and regulation in ciliates.
Michael Santana has a Bachelor of Science in Behavioral Neuroscience from Lehigh University. He has skills in genetics, microbiology, and neurobiology techniques. He has conducted research on bacteriophages that infect Mycobacteria and on the role of genes in zebrafish skeletal morphogenesis. He has volunteered at a behavioral health unit and participated in an international medical campaign in Peru.
Essa Alharby is seeking a full-time position in a research team dedicated to addressing biological questions at the gene, protein, and cellular levels to advance diagnostics and treatments for human diseases. They have a Master's degree in Molecular and Cell Biology and experience in genetic research experiments including DNA sequencing, cloning, and analysis. Their graduate research focused on studying miRNAs related to neurodegenerative disorders using C. elegans models.
Lindsay Jordan has over 15 years of experience in the pharmaceutical industry, specializing in immunology techniques including cell culture, molecular biology, and ELISA development. She has worked at Biothera Pharmaceuticals since 2007 where she developed and validated potency assays, authored SOPs, and supported clinical trials. Prior to this, she held positions at 3M Pharmaceuticals and ViroMED Laboratories, optimizing assays and discovering drug mechanisms of action. Jordan has a Bachelor's degree in Biology and is proficient in laboratory techniques and data analysis software. She has authored multiple publications and presentations on topics including beta-glucan immunology and cancer immunotherapy.
This resume summarizes the qualifications of Jane Yang, a scientist with extensive experience in cancer biology, transcriptional and epigenetic regulation, and cell differentiation. She has over 15 years of research experience, including positions at Genentech and Stanford University where she led projects discovering new mechanisms of action for small molecule inhibitors and identifying protein complexes involved in cell fate decisions. Her publications include high-impact articles in journals such as Cell Death and Differentiation and Genes & Development. She has strong skills in molecular and biochemical techniques and has received competitive NIH funding and honors for her work.
This document provides information about the 2017 commencement ceremony for the Graduate School of Biomedical Sciences, including the names and backgrounds of students receiving Masters of Science degrees. It lists the names, thesis titles, research interests, and future plans of 24 students graduating with Masters degrees in various fields including immunology, infection, dental science, and biomedical engineering. It also recognizes some students for awards and accomplishments.
This document summarizes research on the use of adeno-associated virus (AAV) as a vector for gene therapy. AAV is a promising delivery method due to its low immunogenicity, ability to target specific cell types, and lack of pathogenicity. The document discusses how AAV is being used experimentally to treat diseases like cystic fibrosis, cancer, and heart disease by delivering therapeutic genes. While challenges remain, AAV vectors appear safer than other methods and have the potential to treat many currently incurable diseases.
This document contains a summary of Sandra G. Nishikawa's skills and experience. She has over 30 years of experience in molecular biology techniques including DNA/RNA isolation, PCR, cloning, sequencing, cell culture and more. She has worked as a research technician for various professors at the University of Calgary studying topics like hepatitis B virus, prion diseases, and cancer.
The document provides a resume for Sandra Sharpe Cohen detailing her extensive experience in virology and immunology research since 1980, including her current role as Assistant Research Scientist at NYU School of Medicine since 1999. It outlines her responsibilities in areas such as research project design, data analysis, assay development, and supervision of lab personnel. Her education and skills in various laboratory techniques are also summarized.
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...SC CTSI at USC and CHLA
In her 60-minute presentation, Professor Charo addressed Ethical Challenges in Trials of Human Genome Editing and Gene Therapy, as gene therapy and genome editing clinical trials involve ethical challenges not always found in other areas of research.
This document provides a curriculum vitae for Dr. Md. Ashraful Haque that includes his educational background, academic awards, research interests, publications, and references. It details that he received a B.Sc.Ag from Bangladesh Agricultural University, an MS from the same university, a PhD from Tokyo University of Agriculture and Technology, and postdoctoral research at Ohio State University. His research focuses on plant genes related to biotic and environmental stresses. He has over 15 publications in peer-reviewed journals and numerous conference presentations.
Richelle SOPKO is a biologist with expertise in kinase signaling pathways. She has extensive experience using techniques like proteomics, RNAi, transgenic animals, and mass spectrometry to identify kinase targets and characterize cellular signaling. Currently a postdoctoral fellow at Harvard Medical School, her work involves mapping phosphorylation pathways in Drosophila and examining crosstalk between survival pathways in blood cells.
Jack Reifert has over 15 years of experience in biomedical research. He received his Ph.D. in Molecular, Cellular, and Developmental Biology from UC Santa Barbara and has worked in both academic and industry research settings. Currently he is a scientist at Serimmune Inc. where he utilizes techniques like peptide display screening and deep sequencing to identify biomarkers and therapeutic candidates for autoimmune diseases.
Quadruple helix dna and epigenetics in rheumatism genesEstefaniaReza
Researchers at Cambridge discovered quadruple-stranded DNA structures in human cancer cells. They believe these quadruplexes may be targeted to halt cancer cell proliferation. Using antibodies, they identified these structures, especially during cell division. A gene with more quadruplex DNA was found to be more susceptible to external interference. Separately, scientists at Johns Hopkins and Karolinska Institutet identified DNA sequences and regulatory tags linked to rheumatoid arthritis by studying white blood cells. Tracking these tags may help improve arthritis treatment by directly targeting implicated genes and tags. Epigenetic studies can help explain links between genetics and diseases.
This document provides an overview of gene therapy and its potential applications in periodontics. It discusses how gene therapy works by introducing functional genes to correct defective genes causing disease. The history and types of gene therapy are described, along with methods of gene delivery using viral and non-viral vectors. Applications of gene therapy in periodontics include using growth factors to regenerate periodontal tissues, developing vaccines against periodontal pathogens, and enhancing host antimicrobial defenses. While gene therapy holds promise, there are also limitations and ethical considerations that require further research before clinical use.
SARS-like cluster of circulating bat coronavirus pose threat for human emergenceThierry Debels
1) Researchers examined the disease potential of SARS-like coronaviruses currently circulating in Chinese horseshoe bat populations.
2) They generated a chimeric virus with the spike protein of a bat coronavirus (SHC014) inserted into a mouse-adapted SARS-CoV backbone.
3) Tests showed the chimeric virus could efficiently infect multiple species' ACE2 receptors, replicate in human airway cells, and cause lung infection and disease in mice, demonstrating its potential threat to humans.
This document reports a case of urinary tract infection caused by Chryseobacterium indologenes in an 86-year-old woman with diabetes and chronic kidney disease. C. indologenes is an uncommon environmental bacteria that can cause infection in immunocompromised patients. The patient was treated with levofloxacin and recovered without complications. C. indologenes is resistant to many antibiotics but susceptible to levofloxacin, which successfully treated the urinary tract infection in this case.
Vicky M.-H. Sung has over 20 years of experience in biomedical research. She received her Ph.D. in Molecular Microbiology and Immunology from the University of Southern California. Her resume summarizes her educational background and work experience conducting independent research projects at prestigious institutions such as Harvard Medical School, the University of California Irvine, and the University of Southern California. She has extensive expertise in areas such as viral infections, stem cell biology, and molecular biology techniques.
Philippa Strong has over 15 years of experience in molecular microbiology in both academia and industry. She has significant expertise in culturing anaerobic bacteria, genetic manipulation, protein purification, and fluorescence microscopy. Her technical skills include protein expression and purification, live cell imaging, PCR, cloning, and bacterial isolation from human samples. She has worked on projects involving C. difficile, acetogenic bacteria, and Campylobacter jejuni. Her roles have included postdoctoral research, developing novel biotherapeutics, and optimizing growth of acetogenic bacteria for chemical production. She has authored several peer-reviewed publications and presented her work at international conferences.
Katrina Welch-Reardon has extensive scientific research experience and seeks a business role in a scientific organization. She has a Ph.D. in Biological Sciences from UC Irvine and certificates in bioscience management. Her career includes roles managing admissions events, scientific writing and project management, and graduate research investigating angiogenesis. She has strong communication, organizational and leadership skills as shown through successful event planning, publishing papers, and managing teams of researchers.
The document provides a summary of Swadesh Das's professional experience and qualifications. It summarizes that he has over 10 years of experience in research, particularly in microbiology and molecular oncology. He currently works as a research faculty at Virginia Commonwealth University, where he manages research projects and pursues patent applications. He has a PhD in Life Science and expertise in areas like molecular biology, cancer research, and biomarker identification.
This document provides a summary of Robert S. Coyne's career experience and qualifications. It outlines his educational background, current position as an Associate Professor at the J. Craig Venter Institute, past appointments, research interests in genomics and ciliate biology, grants awarded, and publications. Coyne has over 30 years of experience in research focusing on genome structure, rearrangement, and regulation in ciliates.
Michael Santana has a Bachelor of Science in Behavioral Neuroscience from Lehigh University. He has skills in genetics, microbiology, and neurobiology techniques. He has conducted research on bacteriophages that infect Mycobacteria and on the role of genes in zebrafish skeletal morphogenesis. He has volunteered at a behavioral health unit and participated in an international medical campaign in Peru.
Essa Alharby is seeking a full-time position in a research team dedicated to addressing biological questions at the gene, protein, and cellular levels to advance diagnostics and treatments for human diseases. They have a Master's degree in Molecular and Cell Biology and experience in genetic research experiments including DNA sequencing, cloning, and analysis. Their graduate research focused on studying miRNAs related to neurodegenerative disorders using C. elegans models.
Lindsay Jordan has over 15 years of experience in the pharmaceutical industry, specializing in immunology techniques including cell culture, molecular biology, and ELISA development. She has worked at Biothera Pharmaceuticals since 2007 where she developed and validated potency assays, authored SOPs, and supported clinical trials. Prior to this, she held positions at 3M Pharmaceuticals and ViroMED Laboratories, optimizing assays and discovering drug mechanisms of action. Jordan has a Bachelor's degree in Biology and is proficient in laboratory techniques and data analysis software. She has authored multiple publications and presentations on topics including beta-glucan immunology and cancer immunotherapy.
This resume summarizes the qualifications of Jane Yang, a scientist with extensive experience in cancer biology, transcriptional and epigenetic regulation, and cell differentiation. She has over 15 years of research experience, including positions at Genentech and Stanford University where she led projects discovering new mechanisms of action for small molecule inhibitors and identifying protein complexes involved in cell fate decisions. Her publications include high-impact articles in journals such as Cell Death and Differentiation and Genes & Development. She has strong skills in molecular and biochemical techniques and has received competitive NIH funding and honors for her work.
This document provides information about the 2017 commencement ceremony for the Graduate School of Biomedical Sciences, including the names and backgrounds of students receiving Masters of Science degrees. It lists the names, thesis titles, research interests, and future plans of 24 students graduating with Masters degrees in various fields including immunology, infection, dental science, and biomedical engineering. It also recognizes some students for awards and accomplishments.
This document summarizes research on the use of adeno-associated virus (AAV) as a vector for gene therapy. AAV is a promising delivery method due to its low immunogenicity, ability to target specific cell types, and lack of pathogenicity. The document discusses how AAV is being used experimentally to treat diseases like cystic fibrosis, cancer, and heart disease by delivering therapeutic genes. While challenges remain, AAV vectors appear safer than other methods and have the potential to treat many currently incurable diseases.
This document contains a summary of Sandra G. Nishikawa's skills and experience. She has over 30 years of experience in molecular biology techniques including DNA/RNA isolation, PCR, cloning, sequencing, cell culture and more. She has worked as a research technician for various professors at the University of Calgary studying topics like hepatitis B virus, prion diseases, and cancer.
The document provides a resume for Sandra Sharpe Cohen detailing her extensive experience in virology and immunology research since 1980, including her current role as Assistant Research Scientist at NYU School of Medicine since 1999. It outlines her responsibilities in areas such as research project design, data analysis, assay development, and supervision of lab personnel. Her education and skills in various laboratory techniques are also summarized.
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...SC CTSI at USC and CHLA
In her 60-minute presentation, Professor Charo addressed Ethical Challenges in Trials of Human Genome Editing and Gene Therapy, as gene therapy and genome editing clinical trials involve ethical challenges not always found in other areas of research.
This document provides a curriculum vitae for Dr. Md. Ashraful Haque that includes his educational background, academic awards, research interests, publications, and references. It details that he received a B.Sc.Ag from Bangladesh Agricultural University, an MS from the same university, a PhD from Tokyo University of Agriculture and Technology, and postdoctoral research at Ohio State University. His research focuses on plant genes related to biotic and environmental stresses. He has over 15 publications in peer-reviewed journals and numerous conference presentations.
Richelle SOPKO is a biologist with expertise in kinase signaling pathways. She has extensive experience using techniques like proteomics, RNAi, transgenic animals, and mass spectrometry to identify kinase targets and characterize cellular signaling. Currently a postdoctoral fellow at Harvard Medical School, her work involves mapping phosphorylation pathways in Drosophila and examining crosstalk between survival pathways in blood cells.
Jack Reifert has over 15 years of experience in biomedical research. He received his Ph.D. in Molecular, Cellular, and Developmental Biology from UC Santa Barbara and has worked in both academic and industry research settings. Currently he is a scientist at Serimmune Inc. where he utilizes techniques like peptide display screening and deep sequencing to identify biomarkers and therapeutic candidates for autoimmune diseases.
Quadruple helix dna and epigenetics in rheumatism genesEstefaniaReza
Researchers at Cambridge discovered quadruple-stranded DNA structures in human cancer cells. They believe these quadruplexes may be targeted to halt cancer cell proliferation. Using antibodies, they identified these structures, especially during cell division. A gene with more quadruplex DNA was found to be more susceptible to external interference. Separately, scientists at Johns Hopkins and Karolinska Institutet identified DNA sequences and regulatory tags linked to rheumatoid arthritis by studying white blood cells. Tracking these tags may help improve arthritis treatment by directly targeting implicated genes and tags. Epigenetic studies can help explain links between genetics and diseases.
This document provides an overview of gene therapy and its potential applications in periodontics. It discusses how gene therapy works by introducing functional genes to correct defective genes causing disease. The history and types of gene therapy are described, along with methods of gene delivery using viral and non-viral vectors. Applications of gene therapy in periodontics include using growth factors to regenerate periodontal tissues, developing vaccines against periodontal pathogens, and enhancing host antimicrobial defenses. While gene therapy holds promise, there are also limitations and ethical considerations that require further research before clinical use.
SARS-like cluster of circulating bat coronavirus pose threat for human emergenceThierry Debels
1) Researchers examined the disease potential of SARS-like coronaviruses currently circulating in Chinese horseshoe bat populations.
2) They generated a chimeric virus with the spike protein of a bat coronavirus (SHC014) inserted into a mouse-adapted SARS-CoV backbone.
3) Tests showed the chimeric virus could efficiently infect multiple species' ACE2 receptors, replicate in human airway cells, and cause lung infection and disease in mice, demonstrating its potential threat to humans.
This document reports a case of urinary tract infection caused by Chryseobacterium indologenes in an 86-year-old woman with diabetes and chronic kidney disease. C. indologenes is an uncommon environmental bacteria that can cause infection in immunocompromised patients. The patient was treated with levofloxacin and recovered without complications. C. indologenes is resistant to many antibiotics but susceptible to levofloxacin, which successfully treated the urinary tract infection in this case.
Vicky M.-H. Sung has over 20 years of experience in biomedical research. She received her Ph.D. in Molecular Microbiology and Immunology from the University of Southern California. Her resume summarizes her educational background and work experience conducting independent research projects at prestigious institutions such as Harvard Medical School, the University of California Irvine, and the University of Southern California. She has extensive expertise in areas such as viral infections, stem cell biology, and molecular biology techniques.
Philippa Strong has over 15 years of experience in molecular microbiology in both academia and industry. She has significant expertise in culturing anaerobic bacteria, genetic manipulation, protein purification, and fluorescence microscopy. Her technical skills include protein expression and purification, live cell imaging, PCR, cloning, and bacterial isolation from human samples. She has worked on projects involving C. difficile, acetogenic bacteria, and Campylobacter jejuni. Her roles have included postdoctoral research, developing novel biotherapeutics, and optimizing growth of acetogenic bacteria for chemical production. She has authored several peer-reviewed publications and presented her work at international conferences.
Katrina Welch-Reardon has extensive scientific research experience and seeks a business role in a scientific organization. She has a Ph.D. in Biological Sciences from UC Irvine and certificates in bioscience management. Her career includes roles managing admissions events, scientific writing and project management, and graduate research investigating angiogenesis. She has strong communication, organizational and leadership skills as shown through successful event planning, publishing papers, and managing teams of researchers.
Romain Banchereau is a computational biologist and translational immunologist focused on analyzing immune cell populations and transcriptional profiles from human disease cohorts. He has expertise in genomics analysis of blood and immune cells from infectious and autoimmune disease patients. Through bioinformatics analysis, he identifies biomarkers for disease diagnosis, prognosis, and response to treatment. He currently works as a research associate applying these skills to study lupus, juvenile arthritis, and complications during pregnancy with SLE.
This curriculum vitae outlines the educational and professional background of Dr. Md. Anowar Khasru Parvez, a professor of microbiology. It details his educational qualifications including multiple PhD and MSc degrees. It also lists his employment history including positions at Jahangirnagar University and the Islamic University in Bangladesh. Finally, it provides an overview of his research expertise, projects, publications, and laboratory techniques.
This document provides a summary of Fengkun Du's career and qualifications. It outlines his experience as a microbiologist with over 7 years working in proteomic research and the wastewater industry. It also details his education including a PhD in Applied and Environmental Microbiology from Georgia State University and collaborations with various universities. His skills include protein purification techniques, cell culture, fermentation, microarray data analysis and more.
Liliana M. Cano is a postdoc at North Carolina State University specializing in genome analyses of filamentous plant pathogens and effector biology. Her research focuses on understanding how pathogen effectors manipulate host physiology to achieve infection. She uses genomics to identify effectors and functional analyses to determine their activity and potential for developing disease resistance in crops. Cano has a PhD in plant-microbe interactions from the University of East Anglia and over 15 peer-reviewed publications. She teaches courses and mentors students in bioinformatics and plant pathology.
This document provides a summary of Ana Gervassi's qualifications and experience. She has over 20 years of experience in immunology, infectious diseases, vaccine research, and program management. She is currently the Cellular Immunology Subcore Director at the Center for AIDS Research and a Senior Scientist at the Center for Infectious Disease Research, where she manages a research laboratory.
Bryan Soper has extensive experience in pharmaceutical competitive intelligence, medical writing, and data analysis. He currently performs contract work analyzing clinical trials and assessing drug approval likelihoods for Genentech. Previously he has analyzed cancer models and clinical trials to identify correlations. He holds a PhD in Molecular Biology from Cornell University and has worked as a postdoctoral scholar at UCSF investigating drug targets.
Molecular Biologist Academic CV for Industry or Private Sector Consideration Sirie Godshalk
Molecular Biologist with over thirteen years of hands-on research experience, impactful writer and presenter, dynamic leader and enthusiastic team player with an eye for great ideas and a passion to move science in new directions seeks challenging opportunities beyond the bench.
Lisa Salvador is a pharmaceutical research professional with over 10 years of industry experience focusing on clinical biomarkers, translational medicine, and drug development. She has a PhD in Cell Biology from Northwestern University and has held senior research roles at Bristol-Myers Squibb and GlaxoSmithKline. Her expertise includes cellular and molecular biology, gene therapy research, and diagnostic assay development. She has received numerous awards for her research contributions and leadership.
Vasudevan Ayyappan is seeking new job opportunities and has over 10 years of experience in molecular biological techniques and 5+ years experience in next generation sequencing, genome editing, and pathway analysis. He has a broad range of skills in mammalian, microbial, and plant research and has effectively collaborated on multiple research projects.
Paul A. Azzinaro is a master scientist seeking employment who has extensive experience in molecular biology, cell biology, and proteomics. He received his Master's degree in cell and molecular biology from the University of Rhode Island, where he investigated the Fanconi anemia DNA repair pathway. His laboratory experience includes work at Plum Island Animal Disease Center developing vaccines and using yeast-2-hybrid and immunofluorescence techniques, as well as previous positions conducting assays and as a teaching assistant.
Jason C. Poole has 17 years of experience as a molecular biologist developing novel molecular and genetic assays. He has a PhD in molecular genetics and most recently worked at EMD Millipore developing qPCR and next generation sequencing assays that were commercialized. He is seeking a senior scientist or project leader position and has strong skills in areas like qPCR, sequencing, cloning, and assay development.
This document provides an overview of recent single cell research publications featuring Illumina technology. It describes applications of single cell sequencing in cancer research, metagenomics, stem cells, immunology and other areas. It discusses techniques for sample preparation, data analysis, and sequencing of DNA, epigenetics and RNA at the single cell level. The document includes a bibliography of reviewed publications demonstrating the use of Illumina sequencing for single cell analysis.
Eric J. Vick is a medical student at the University of Tennessee Health Science Center with research interests in innate immunity, immune checkpoint inhibitors, and T cell lymphoma. He received his M.D. from the University of Tennessee Health Science Center in 2018 and his Ph.D. in Molecular Biosciences from Middle Tennessee State University in 2014, where he studied the human inflammatory response to Gardnerella vaginalis. He has published peer-reviewed articles, presented his research at several conferences, and received honors including a Medical Student Research Fellowship.
This document provides a summary of Tibor Farkas's qualifications and experience. He has over 20 years of experience in microbiology and virology research, particularly regarding enteric viruses, at Cincinnati Children's Hospital and previously in Hungary. His research accomplishments include the discovery and characterization of several novel viral pathogens. He has strong skills in laboratory techniques, experimental design, and leadership.
Katherine A. Owen is a scientific research consultant with over 15 years of experience in cell biology, microbiology, and immunology. She currently works as a scientific consultant for the Center for Open Science, providing literature reviews and data analysis for published reports. Previously, she held research faculty and instructor positions at the University of Virginia, where she managed multiple research projects resulting in publications. Her expertise includes multidisciplinary collaboration, writing, primary research techniques, project management, public speaking, and data analysis.
James J. Campbell has had an extensive career in immunology research. He is currently a Senior Director at ChemoCentryx, where he leads pre-clinical research teams investigating drug mechanisms of action. Previously, he was a Principal Investigator and Professor at Harvard Medical School, where he managed an immunology lab and published over 60 peer-reviewed papers. He has received many awards and honors for his research and expertise in T cell biology, chemokines, and skin and intestinal immunity.
The document summarizes activities of the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP). It outlines the center's mission to improve diagnosis, prevention and control of infectious diseases through training and research. It then provides details on awards received, including grants from Wellcome Trust and scholarships. It discusses the center's program activities like short courses conducted, new master's and PhD programs launched, faculty and student internships, and publications by faculty. In summary, the document reports on WACCBIP's progress in achieving its mission through various training and research initiatives.
This resume is for Jon Vermeire, who has extensive experience in biological research focusing on parasitic helminths like hookworms. He is currently an Assistant Researcher at the University of California, San Francisco researching hookworm disease models. Previously he held positions at Yale University and the University of Wisconsin. Mr. Vermeire has a wide range of expertise including pathology, epidemiology, immunology, and parasitology. He has published several papers and is a member of professional organizations like the American Society of Parasitologists.
1. Alex Michael Ward
alex.m.ward88@gmail.com
415-942-3393
812 Corriente Point Drive
Redwood City, California 94065
Professional Profile
A motivated and technically skilled virologist and cell biologist seeking a research position in the
Biotech industry. I have 14 years experience developing genetic, proteomic and cell-based
approaches to study virus-host interaction and identify therapeutic targets. I am a highly
collaborative and creative scientist with solid management, mentoring and communication skills
and a strong track record of publications and independent funding.
Work History
Assistant Professor: Program in Emerging Infectious Diseases, Duke-National University of
Singapore Graduate Medical School, Jan 2014-present
Post-doctoral Research: Laboratory of Molecular Virology, Duke-National University of
Singapore Graduate Medical School, Aug 2008-Dec 2013, Research advisor: Dr. Mariano A.
Garcia-Blanco
Education
Microbiology, Ph.D.: University of Virginia, Charlottesville, Virginia, Aug 2008
Research advisors: Dr. David Rekosh and Dr. Marie-Louise Hammarskjöld
• Mechanism of action of an antisense RNA-based anti-HIV therapeutic
• Effects of cis-acting RNA elements on nonsense-mediated decay
Biology, B.A.: Reed College, Portland, Oregon, May 1998
Professional Accomplishments
• Developed novel cell-free and cell-based assays, such as:
o Generated molecular clones of HIV-1 and Enterovirus 71 isolates for reverse
genetic studies and expression of antisense RNA
o Optimized cell culture techniques for plasmid and siRNA transfection
o Developed ELISA and plaque assays for measuring viral growth
o Studied intracellular viral replication using luciferase replicon reporter systems
o Utilized qPCR and northern blot techniques for quantitative RNA assays
o Utilized ELISA and western blot techniques for quantitative protein assays
o Developed RNA chromatography platform for purification of Retrovirus,
Flavivirus, Hepacivirus and Enterovirus RNA binding proteins (lab and clinical
isolates)
o Cloned, expressed and purified proteins in bacteria and mammalian cells
• Independently managed a research team for more than four years, including regulatory
oversight, budget management, scientific mentorship, and obtaining external funding.
• Presented at local and international meetings, served as primary and contributing author
on publications, and collaborated on basic and clinical virology research projects.
2. Alex Michael Ward Page 2 of 4
Publications
Journal Articles
Lopez, CM, Saminathan, K, Gunaratne, J, Ward, AM, QKI binds the 5’ UTR of EV71 and is
required for EV71 replication. Manuscript in preparation.
Ward AM, Gunaratne, J, Garcia-Blanco, MA, The role of cellular exonuclease ERI3 in
Dengue virus replication. Manuscript in preparation.
Manokaran G, Finol E, Wang C, Gunaratne J, Bahl J, Ong EZ, Tan HC, Sessions OM, Ward
AM, Gubler DJ, Harris E, Garcia-Blanco MA, Ooi EE, Subgenomic RNA of dengue virus
binds tripartite motif 25 protein to inhibit interferon expression for epidemiological
fitness. Science published online 2 July 2015
Ward AM, Bidet K, Yinglin A, Ler SG, Hogue K, Blackstock W, Gunaratne J, Garcia-Blanco MA,
Quantitative mass spectrometry of DENV-2 RNA-interacting proteins reveals that the
DEAD-box RNA helicase DDX6 binds the DB1 and DB2 3' UTR structures. RNA Biology
2011 8: 1173-86
Ward AM, Rekosh D and Hammarskjöld ML, Trafficking Through the Rev/RRE Pathway is
Essential for Efficient Inhibition of HIV-1 by an Antisense RNA derived from the Envelope
Gene. Journal of Virology 2009 83: 940-52
Grossmann KF, Ward AM, Matkovic ME, Folias AE, Moses RE, S. cerevisiae has three
pathways for DNA interstrand crosslink repair. Mutation Research 2001 487: 73-83
Grossmann KF, Ward AM, Moses RE, Saccharomyces cerevisiae lacking Snm1, Rev3 or
Rad51 have a normal S-phase but arrest permanently in G2 after cisplatin treatment.
Mutation Research 2000 461: 1-13
Book Chapters
Ward, AM, Gunaratne, J, Garcia-Blanco, MA, Identification of Dengue RNA Binding Proteins
using RNA Chromatography and Quantitative Mass Spectrometry. In: Methods in
Molecular Biology 2014 1138: 253-70
Barrows, N, Bradrick, S, Bidet, K, Anwar, A, Ward, AM, Jamison, SF, Levitt, B, LeSommer, C
and Garcia-Blanco, MA, The Interface between Dengue Virus and the Human Host. In:
Dengue and Dengue Hemorrhagic Fever, 2nd
ed. Gubler, DJ et al., eds., 2014
Funding
NMRC Cooperative Basic Research Grant (CBRG)-New Investigator Grant (BNIG11nov010),
2012-2014, Defining the function of ERI3 in DENV replication and selection of RNA
aptamers that inhibit ERI3 activity. Role: PI, SGD 189,000.00
NMRC Clinician-Scientist Individual Research Grant (NMRC/CIRG/1374/2013), 2014-2017,
Defining the role of 3’ untranslated region of the dengue virus genome in determining the
viral fitness and epidemic dengue. Role: Collaborator, SGD 1,167,272.00
3. Alex Michael Ward Page 3 of 4
NMRC CBRG-New Investigator Grant (BNIG13nov029), 2014-2016, The molecular basis for
EV71 pathogenesis and epidemic potential. Role: Collaborator, SGD 200,000.00
NMRC CBRG (CBRG14may057), 2015-2018, Characterization of innate immune disruption
by flaviviral subgenomic RNA (sfRNA), Role: PI, SGD 1,100,000.00
NMRC CBRG-NIG (BNIG14nov007), The impact of sequence evolution in the dengue non-
coding RNA on mosquito transmission. Role: Co-Investigator, SGD 198,000.00, Pending
budget revision
Select Presentations
Oral Presentations
Ward AM, Jamison, SF, Levitt, B, Gunaratne J, Garcia-Blanco, MA, Identification and
characterization of 3’-5’ exonucleases required for dengue virus replication, 2012
RiboClub Annual Meeting, Sep 24-26, 2012, Orford, Quebec
Ward AM, Gunaratne, J, Hogue, K, Blackstock WA, Garcia-Blanco, MA, Identification of a
host cell factor that binds to the Dengue 2 untranslated region, 4th
Asia Dengue Research
Network Meeting, Dec 8-11, 2009, Singapore
Ward AM, Hammarskjöld ML and Rekosh D, Regions of the HIV-1 Rev Response Element
outside of the primary Rev binding site are required for viral replication, Workshop on
Post-Trancriptional Control by Oncogenic Viruses, Jun 24-27, 2004, Park City, Utah
Poster Presentations
Ward, AM, Jamison, S, Levitt, B, Dominski, Z, Marzluff, WF, Gunaratne, J, and Garcia-Blanco
MA, Identification and characterization of a 3’-5’ exonuclease that binds to dengue virus
RNA and is required for viral replication, Keystone Symposium on Positive Strand RNA
Viruses, Apr 28-May 3, 2013, Boston, Massachusetts
Ward, AM, Bidet, K, Yinglin, A, Gunaratne, J, Hogue, K, Blackstock, W, Garcia-Blanco, MA,
Characterization of Host Cell Proteins that Interact with the DENV-2 RNA 5’ and 3’ UTRs
reveals a role for DDX6 in packaging of viral RNA, 16th Annual Meeting of the RNA Society,
Jun 14-18, 2011, Kyoto, Japan
Ward AM, Rekosh D, and Hammarskjöld ML, The HIV-1 Rev Response Element (RRE)
significantly improves antisense RNA targeting, 14th Conference on Retroviruses and
Opportunistic Infections, Feb 25-28, 2007, Los Angeles, California
Teaching Experience
Lecturer, Cellular Mechanisms, Graduate course at the National University of Singapore and
Temasek Lifesciences Laboratory, Sep 2014-present, Lectures on: Cellular stress response
Lecturer, Principles of Infectious Diseases, Graduate course at the Duke-NUS Graduate
Medical School, Jan 2014-present, Lectures on: Virus replication, Cell biology of viruses and
Picornaviridae
4. Alex Michael Ward Page 4 of 4
Lecturer, Transforming Medicine: From Bench to Bedside and Beyond, Undergraduate course
at the National University of Singapore, Singapore, Sep 2011-present, Lectures on: Emerging
Infectious Diseases
Instructor (lecture and practical), Molecular Biology of the Cell, Undergraduate course at the
School of Life and Physical Sciences, PSB Academy, Singapore, May 2010-Aug 2011, Lectures
on: Cytokinesis, Cell organelles, Cell membranes, Ion channels, Protein trafficking and
secretion, Biochemical messages, Cell signaling, Cell structure, DNA structure, replication,
mutation and repair
Professional Experience
2013-present, Organizer, Progress on Research in Emerging Infectious Diseases (PREID)
meeting
2012-present, Trainee, Academic Medicine Education Institute, Duke-NUS and SingHealth
2010-present, Member, Review Editorial Board, Frontiers in Genomic Assay Technology
Scientific Awards
2007, 2005 and 2004, Young Investigator Award, Conference on Retroviruses and
Opportunistic Infections
2000-2001, National Institutes of Health Cancer Training Grant
1998, Howard Hughes Medical Institute Equipment Grant
Professional Memberships
RNA Society
American Society of Microbiology
References
Mariano A Garcia-Blanco, M.D., Ph.D.
Professor and Chair
Department of Biochemistry & Molecular
Biology
University of Texas Medical Branch
108 Basic Science Building
301 University Boulevard
Galveston, TX 77555 USA
+1 409 772-2271
maragarc@utmb.edu
Eng Eong Ooi, B.M., Ph.D.
Associate Professor and Deputy Program
Director
Program in Emerging Infectious Diseases
Duke-NUS Graduate Medical School
8 College Road
Singapore 169857
+65 6485 7238
engeong.ooi@duke-nus.edu.sg
David Rekosh, Ph.D. and Marie-Louise
Hammarskjöld, M.D., Ph.D.
Professors of Microbiology
Myles H. Thaler Center for AIDS and
Human Retrovirus Research
University of Virginia
PO Box 800734
Charlottesville, Virginia 22908 USA
+1 434 982-1599
dr4u@virginia.edu
mh7g@virginia.edu
Jayantha Gunaratne, Ph.D.
Group Leader
Quantitative Proteomics Group
Institute of Molecular and Cell Biology
61 Biopolis Drive
Proteos
Singapore 138673
+65 6586 9689
jayanthag@imcb.a-star.edu
雅虎竞拍
煤炉代买
paypay商城
乐天二手
日本亚马逊
乐天新品
ZOZOTOWN
